Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial

A. Hirsch, R. Nijveldt, P.A. van der Vleuten, J.G.P. Tijssen, W.J. Giessen, R.A. Tio, J. Waltenberger, J.M. ten Berg, P.A. Doevendans, W.R.M. Aengevaeren, JJ Zwaginga, B.J. Biemond, A.C. van Rossum, J.J. Piek, F. Zijlstra

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1736-1747
JournalEuropean Heart Journal
Volume32
Issue number14
DOIs
Publication statusPublished - 2011

Cite this